603739.SH
Qingdao Vland Biotech, Inc.
SSE · Healthcare · Biotechnology · CN
CNY 12.05
−1.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 38.25x
- P/E 2027E
- 36.00x
- P/E 2028E
- 33.08x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 43.68x
- PEG TTM
- —
- Price / book
- 1.72x
- Price / sales
- 2.21x
- Price / cash flow
- 24.86x
Enterprise value
- Enterprise value
- CNY 3.7B
- EV / sales
- 2.62x
- EV / EBITDA
- 14.90x
- EV / EBIT
- 27.09x
- Market cap
- CNY 3.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026